Login prior to clicking the links below

SESSION I – HOT TOPICS IN RENAL CELL CARCINOMA
Welcome and Introduction of Program Co-Chairs	Anil Kapoor	VIEW
Welcome: Overview of Program, Speakers and Meeting Objectives	Sébastien Hotte, Ricardo Rendon	VIEW
KEYNOTE LECTURE: CARMENA and the Role of Cytoreductive Nephrectomy in 2019	Laurence Albiges	VIEW
KEYNOTE LECTURE: Emerging IO-based doublets in mRCC	Brian Rini	VIEW
SESSION II – TRANSLATIONAL AND GENETIC RESEARCH
Biomarkers in Metastatic RCC: Too Hot, Too Cold, or Just Right	Aly-Khan Lalani	VIEW
KEYNOTE LECTURE: 2nd Line Real World Data for IO in RCC	Laurence Albiges	VIEW
KEYNOTE LECTURE: Germline Testing in Hereditary Kidney Cancer Syndromes	Mark Ball	VIEW
Update and Development of 2018 Clinical Research Mainstreaming Genetics VHL Database Project Update	Raymond Kim	VIEW
Immune-Potentiating Impact of the Gut Microbiome on Kidney Cancer Immune Infiltrate: A Novel Predictor of Immune Checkpoint Inhibitors Response	Bertrand Routy	VIEW
Identifying Prognostic and Predictive Biomarkers in Metastatic Renal-Cell Carcinoma: An Exploratory Study of the International Metastatic Renal‐Cell Carcinoma Database Consortium (IMDC) Tissue Biorepository	Shaan Dudani	VIEW
CKCis Update Report: Data, Recent Publications and Ongoing Research	Naveen Basappa, Rodney Breau	VIEW
KEYNOTE LECTURE: Neo/Adjuvant Approaches, Translational Gene Expression Data in Localized and mRCC	Brian Rini	VIEW
Clinical Trials Update, Opportunities, and Ongoing Projects in Canada
PROSPER	Anil Kapoor	VIEW
non-clear cell RCC	Danny Heng	VIEW
Other	Christian Kollmannsberger	VIEW
Kidney Cancer Canada Updates	Stephen Andrew, Andrew Weller	VIEW
SESSION III – OPTIMAL MANAGEMENT OF PRIMARY TUMORS IN RCC
KEYNOTE LECTURE: Management of High Risk Cystic Lesions	Michael Blute	VIEW
KEYNOTE LECTURE: The Abscopal Effect of Radiation Therapy: What is it and How Can We Use it in Kidney Cancer?	William Chu	VIEW
The Evolving Role of Non Surgical Therapeutic Options in RCC:
1. SBRT	Anand Swaminath	VIEW
2. RFA	Anil Kapoor	VIEW
Discussion	Anand Swaminath, Anil Kapoor	VIEW
SESSION IV – SURVIVOR AND ADVOCACY
IKCC – Current Initiatives and Future Plans	Deb Maskens	VIEW
Living with Chronic Toxicities: Healthcare Teams and Patients Working Together
1. Physician’s Input	Lori Wood	VIEW
2. A Patient’s Perspective	Stephen Andrew	VIEW
SESSION V: FUTURE OF RENAL CELL CARCINOMA
KEYNOTE LECTURE: Surgical Management of Hereditary Kidney Cancer Syndromes	Mark Ball	VIEW
Joint Moderated Case Discussion Session on the Role of CN in mRCC	Michael Blute and Laurence Albiges	VIEW
IMDC: Current Questions and Development of Heng Criteria 2.0	Danny Heng	VIEW
Kidney Cancer Population-Based Research: Real-Life Examples	Pierre Karakiewicz	VIEW
Translational Research	Alan So	VIEW
Progress Report, Grant Winners, and Future Discussion	Anil Kapoor	VIEW